Free shipping on all orders over $ 500

Adefovir Dipivoxil

Cat. No. M5050
Adefovir Dipivoxil Structure

GS 0840

Size Price Availability Quantity
10mM*1mL USD 65  USD65 In stock
50mg USD 50  USD50 In stock
100mg USD 80  USD80 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

Adefovir Dipivoxil reduces Liver HBV DNA to <0.1 pg of viral DNA per mg of total DNA (pg/mg) in transgenic mice expressing hepatitis B virus. Adefovir Dipivoxil treatment also reduces serum HBV DNA to 3.5 log10 genomic equivalents (ge)/mL in transgenic mice expressing hepatitis B virus compared to 5.3 log10 ge/mL for the placebo control group. Adefovir Dipivoxil antiviral activity reaches near maximum viral reduction by day 10 in the liver and reaches an endpoint of liver virus inhibition at 1.0 mg/kg/day. Adefovir Dipivoxil works by blocking reverse transcriptase, an enzyme that is crucial for the hepatitis B virus (HBV) to reproduce in the body. Adefovir Dipivoxil is used for treatment of hepatitis B and herpes simplex virus infection.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 501.47
Formula C20H32N5O8P
CAS Number 142340-99-6
Purity >98%
Solubility DMSO 100 mg/mL
Water <1 mg/mL
Storage at -20°C

[1] Manolakopoulos S, Aliment Pharmacol Ther. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.

[2] Marcellin P, N Engl J Med. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

[3] Julander JG, Antiviral Res. Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.

Related Reverse Transcriptase Products

Efavirenz is a synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral activity.


Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.


Didanosine is a reverse transcriptase inhibitor with an IC50 of 0.49 μM.


Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor with an IC50 of 2.7 mM.


Zalcitabine is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI).

Abmole Inhibitor Catalog

Keywords: Adefovir Dipivoxil, GS 0840 supplier, Reverse Transcriptase, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.